JSFC Sistema (AFKS):企業の財務・戦略的SWOT分析

◆英語タイトル:JSFC Sistema (AFKS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C13841
◆発行会社(調査会社):GlobalData
◆発行日:2019年2月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ロシア
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

JSFC Sistema (AFKS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

JSFC Sistema (Sistema) is a diversified holding company, which offers a wide range of consumer services in Russia and the Commonwealth of Independent States (CIS). The company undertakes businesses in various sectors, including telecommunications, high technology, real estate development, retail, finance, timber processing, mass media, banking, agriculture, pulp and paper, hospitality, railway transportation, pharmaceuticals and healthcare. The company carries out the operations through its subsidiaries Mobile TeleSystems, MTS BanK, RTI, Detsky mir-Center, Segezha Group, Leader Invest and Business Nedvizhimost, Cosmos Group, Medsi, Bashkir Power Grid Company (BPGC), Agro holding and Binnopharm. It conducts business operations in Russia and other countries. Sistema is headquartered in Moscow, Russia.

JSFC Sistema Key Recent Developments

Feb 15,2019: Johnson & Johnson Innovation Names Winners of Inaugural Champions of Science – Africa Storytelling Challenge
Feb 12,2019: U.S. FDA Approves DARZALEX® (daratumumab) Split-Dosing Regimen
Feb 06,2019: Sistema successfully completes secondary placement of series 001P-07 bonds

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
JSFC Sistema – Key Facts
JSFC Sistema – Key Employees
JSFC Sistema – Key Employee Biographies
JSFC Sistema – Major Products and Services
JSFC Sistema – History
JSFC Sistema – Company Statement
JSFC Sistema – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
JSFC Sistema – Business Description
Business Segment: Corporate
Overview
Performance
Business Segment: Detsky Mir
Overview
Performance
Key Stats
Business Segment: MTS
Overview
Performance
Key Stats
Business Segment: MTS Bank
Overview
Performance
Business Segment: RTI
Overview
Performance
Key Stats
Geographical Segment: Other
Performance
Geographical Segment: Russia
Performance
JSFC Sistema – Corporate Strategy
JSFC Sistema – SWOT Analysis
SWOT Analysis – Overview
JSFC Sistema – Strengths
JSFC Sistema – Weaknesses
JSFC Sistema – Opportunities
JSFC Sistema – Threats
JSFC Sistema – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
JSFC Sistema, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 15, 2019: Johnson & Johnson Innovation Names Winners of Inaugural Champions of Science – Africa Storytelling Challenge
Feb 12, 2019: U.S. FDA Approves DARZALEX® (daratumumab) Split-Dosing Regimen
Feb 06, 2019: Sistema successfully completes secondary placement of series 001P-07 bonds
Dec 28, 2018: Sistema and VTB to create a major pharmaceuticals holding
Dec 01, 2018: DARZALEX® (daratumumab) Combination Regimens Show Positive Results for Newly Diagnosed and Relapsed Patients with Multiple Myeloma
Nov 27, 2018: Sistema reports results for Q3 2018
Oct 02, 2018: El Tulane National Primate Research Center recibe el sistema PET precl nico Mediso n mero 100
Sep 19, 2018: Sistema Medsi and RDIF sign agreement with South Korean biotechnology company Green Cross Cell
Sep 18, 2018: Janssen Submits New Drug Application to U S FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer[TOPC : Tech - JSFC Sistema]
Sep 12, 2018: Sistema Medsi and RDIF sign agreement with South Korean biotechnology company Green Cross Cell[TOPC : Tech - JSFC Sistema]
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
JSFC Sistema, Key Facts
JSFC Sistema, Key Employees
JSFC Sistema, Key Employee Biographies
JSFC Sistema, Major Products and Services
JSFC Sistema, History
JSFC Sistema, Subsidiaries
JSFC Sistema, Key Competitors
JSFC Sistema, Ratios based on current share price
JSFC Sistema, Annual Ratios
JSFC Sistema, Annual Ratios (Cont...1)
JSFC Sistema, Annual Ratios (Cont...2)
JSFC Sistema, Interim Ratios
JSFC Sistema, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
JSFC Sistema, Performance Chart (2013 - 2017)
JSFC Sistema, Ratio Charts

★海外企業調査レポート[JSFC Sistema (AFKS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Taiko Bank Ltd:企業の戦略・SWOT・財務情報
    The Taiko Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Taiko Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Wendy’s Company:企業の戦略・SWOT・財務情報
    The Wendy’s Company - Strategy, SWOT and Corporate Finance Report Summary The Wendy’s Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Spitfire Oil Ltd (SRO):企業の財務・戦略的SWOT分析
    Summary Spitfire Oil Ltd (Spitfire) is an oil and gas company that produces and markets liquid hydrocarbons. The company's liquid hydrocarbons include fuel oil and distillate from the Salmon Gums Lignite Deposit. Its Salmon Gums Lignite deposit is located in Western Australia near Salmon Gums and co …
  • GR. Sarantis S.A.:企業の戦略・SWOT・財務情報
    GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report Summary GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CooperVision Inc:医療機器:M&Aディール及び事業提携情報
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • VistaGen Therapeutics Inc (VTGN):企業の財務・戦略的SWOT分析
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • Mckesson Europe AG (CLS1):企業の財務・戦略的SWOT分析
    Mckesson Europe AG (CLS1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • EPAM Systems Inc (EPAM):企業の財務・戦略的SWOT分析
    EPAM Systems Inc (EPAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • RainDance Technologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary RainDance Technologies Inc (RDT) is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA. It also offers RainDrop Plus digital PCR s …
  • Regenera Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Regenera Pharma Ltd (Regenera Pharma) is a pharmaceutical company that develops a novel drug for neurological indications. The company provides product RPh201, which is a botanical drug developed to repair permanent damages caused by neurological diseases that afflict the central nervous sys …
  • Alkane Energy Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Alkane Energy Plc (Alkane Energy), a subsidiary of Basalt Infrastructure Partners LLP, is a diversified company. The company power from coal mine methane and natural gas facilities. It has natural gas, coal bed methane, coal mine methane and shale gas. Alkane Energy design, builds and operat …
  • LG Uplus Corp:企業の戦略・SWOT・財務情報
    LG Uplus Corp - Strategy, SWOT and Corporate Finance Report Summary LG Uplus Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • InfuSystem Holdings Inc (INFU):企業の財務・戦略的SWOT分析
    Summary InfuSystem Holdings Inc (InfuSystem) is a provider of infusion pumps and related services. The company provides ambulatory infusion pumps and associated clinical services. Its patient services comprise infucare help hotline, infuease, education, and pain management. InfuSystem offers pumps a …
  • Orca Gold Inc (ORG):企業の財務・戦略的SWOT分析
    Summary Orca Gold Inc (Orca Gold), formerly Canaco Resources Inc, subsidiary of Pinetree Capital Ltd, is a gold exploration company. The company's activities include acquisition, exploration and development of mineral properties in North and West Africa. It holds interests in The Block 14 gold proje …
  • Ecsponent Ltd (ECS):企業の財務・戦略的SWOT分析
    Ecsponent Ltd (ECS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Resverlogix Corp (RVX)-製薬・医療分野:企業M&A・提携分析
    Summary Resverlogix Corp (Resverlogix) is an epigenetics company that develops small molecule therapeutics for Bromodomain and ExtraTerminal Domain (BET) inhibition. The company provides lead product such as RVX-208 (apabetalone), is a BET inhibitor under phase III clinical trial. Its RVX-208 is bei …
  • Schneider Electric SE (SU):石油・ガス:M&Aディール及び事業提携情報
    Summary Schneider Electric SE (Schneider Electric), formerly Schneider Electric SA, is an energy management and automation company that develops related technologies and solutions for electricity distribution. Its product line includes automation and control products, building management and securit …
  • Provectus Biopharmaceuticals Inc (PVCT):医療機器:M&Aディール及び事業提携情報
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Sinocare Inc (300298):医療機器:M&Aディール及び事業提携情報
    Summary Sinocare Inc (Sinocare) is a medical device company that focuses on the research, development, manufacturing and commercialization of diagnosis testing products for diabetes and other chronic diseases. Its product portfolio comprises mobile glucose meter, portable automatic biochemical analy …
  • Securian Financial Group, Inc.:企業の戦略・SWOT・財務情報
    Securian Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Securian Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆